Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Laboratorios Normon deeptech, Pharmaceutical Manufacturing | Other 4 May 2024 | | ||
Stadt Ulm Government Administration | Other 11 Apr 2024 | | ||
Formycon AG biotech, deeptech | Other 16 Apr 2024 | | ||
L'Usine Nouvelle Newspaper Publishing | Other 22 Sep 2017 17 Apr 2024 | | | |
The Kinetix Group-Powered by PetauriTM Hospitals and Health Care | Other 25 Mar 2024 | | ||
mAbxience biotech, deeptech, Biotechnology Research | Other 1 Aug 2024 | | ||
PM Society healthtech, martech, Advertising Services | Other 21 Mar 2024 | | ||
Abingworth Venture Capital and Private Equity Principals | Other 1 Apr 2024 | | ||
Closed Loop Medicine biotech, deeptech, healthtech, Biotechnology Research | Other 27 Mar 2024 | | ||
Research and Markets Market Research | Other 21 Feb 2024 | |